General Information
Eltrombopag olamine a type of thrombopoietin receptor agonist and is used to treat thrombocytopenia (a lower-than-normal number of platelets in the blood) in patients with chronic immune thrombocytopenic purpura (a condition in which platelets are destroyed by the immune system).
About the API
Technology
Synthetic
Molecular Weight
564.6 g/mol
Therapeutic category
Hematology
Available formulations
Oral Solid
Regulations
EU DMF